share_log

The Total Return for Hubei Xingfa Chemicals Group (SHSE:600141) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years

The Total Return for Hubei Xingfa Chemicals Group (SHSE:600141) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years

在過去五年中,湖北興發化工集團(SHSE: 600141)投資者的總回報增長速度快於收益增長
Simply Wall St ·  01/11 19:38

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the market average. And the truth is, you can make significant gains if you buy good quality businesses at the right price. To wit, the Hubei Xingfa Chemicals Group share price has climbed 83% in five years, easily topping the market return of 25% (ignoring dividends).

一般而言,積極選股的目的是尋找回報優於市場平均水平的公司。事實是,如果你以合適的價格購買高質量的企業,你可以獲得可觀的收益。換句話說,湖北興發化工集團的股價在五年內上漲了83%,輕鬆超過了25%的市場回報率(不計股息)。

Although Hubei Xingfa Chemicals Group has shed CN¥711m from its market cap this week, let's take a look at its longer term fundamental trends and see if they've driven returns.

儘管湖北興發化工集團本週的市值下跌了7.11億元人民幣,但讓我們來看看其長期基本面趨勢,看看它們是否推動了回報。

See our latest analysis for Hubei Xingfa Chemicals Group

查看我們對湖北興發化工集團的最新分析

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

不可否認的是,市場有時是有效的,但價格並不總是能反映基本的業務表現。評估公司情緒變化的一種有缺陷但合理的方法是將每股收益(EPS)與股價進行比較。

During five years of share price growth, Hubei Xingfa Chemicals Group achieved compound earnings per share (EPS) growth of 37% per year. This EPS growth is higher than the 13% average annual increase in the share price. So one could conclude that the broader market has become more cautious towards the stock. The reasonably low P/E ratio of 7.17 also suggests market apprehension.

在五年的股價增長中,湖北興發化工集團實現了每年37%的複合每股收益(EPS)增長。每股收益的增長高於股價年均增長13%。因此,人們可以得出結論,整個市場對該股變得更加謹慎。相當低的市盈率爲7.17,也表明了市場的擔憂。

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

下圖描繪了 EPS 隨着時間的推移而發生的變化(點擊圖片顯示確切的數值)。

earnings-per-share-growth
SHSE:600141 Earnings Per Share Growth January 12th 2024
SHSE: 600141 每股收益增長 2024 年 1 月 12 日

We know that Hubei Xingfa Chemicals Group has improved its bottom line over the last three years, but what does the future have in store? You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

我們知道湖北興發化工集團在過去三年中提高了利潤,但是未來會發生什麼?您可以在這張免費的交互式圖片中看到其資產負債表如何隨着時間的推移而增強(或減弱)。

What About Dividends?

那股息呢?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. We note that for Hubei Xingfa Chemicals Group the TSR over the last 5 years was 101%, which is better than the share price return mentioned above. This is largely a result of its dividend payments!

在考慮投資回報時,重要的是要考慮兩者之間的區別 股東總回報率 (TSR) 和 股價回報。股東總回報率是一種回報計算方法,它考慮了現金分紅的價值(假設收到的任何股息都經過再投資)以及任何貼現資本籌集和分拆的計算價值。可以說,股東總回報率更全面地描述了股票產生的回報。我們注意到,湖北興發化工集團過去5年的股東總回報率爲101%,好於上述股價回報率。這在很大程度上是其股息支付的結果!

A Different Perspective

不同的視角

We regret to report that Hubei Xingfa Chemicals Group shareholders are down 36% for the year (even including dividends). Unfortunately, that's worse than the broader market decline of 13%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. On the bright side, long term shareholders have made money, with a gain of 15% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand Hubei Xingfa Chemicals Group better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 4 warning signs with Hubei Xingfa Chemicals Group (at least 1 which doesn't sit too well with us) , and understanding them should be part of your investment process.

我們遺憾地報告,湖北興發化工集團的股東今年下跌了36%(甚至包括股息)。不幸的是,這比整個市場13%的跌幅還要嚴重。話雖如此,在下跌的市場中,一些股票不可避免地會被超賣。關鍵是要密切關注基本發展。好的一面是,長期股東賺了錢,在過去的五年中,每年增長15%。最近的拋售可能是一個機會,因此可能值得查看基本面數據以尋找長期增長趨勢的跡象。長期跟蹤股價表現總是很有意思的。但是,要更好地了解湖北興發化工集團,我們需要考慮許多其他因素。例如,投資風險的幽靈無處不在。我們已經向湖北興發化工集團確定了4個警告信號(至少有1個不太適合我們),了解這些信號應該是您投資過程的一部分。

We will like Hubei Xingfa Chemicals Group better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我們看到一些重大的內幕收購,我們會更喜歡湖北興發化工集團。在我們等待的同時,請查看這份免費清單,列出了最近有大量內幕收購的成長型公司。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報率。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St 的這篇文章本質上是籠統的。我們僅使用公正的方法提供基於歷史數據和分析師預測的評論,我們的文章並非旨在提供財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不會考慮最新的價格敏感型公司公告或定性材料。華爾街只是沒有持有上述任何股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論